Pharmaceutical MNCs Reap Bigger China Market Share
This article was originally published in PharmAsia News
Executive Summary
China's pharmaceutical industry constitutes a key sector for overseas investment. In 2006, 1,500 joint ventures and multinational companies made up 30 percent of drug manufacturers in the country. Foreign corporations accounted for 27 percent of China's medical revenue, capturing up to 65 percent and 80 percent of the market for drugs and medical devices, respectively. China Chamber of Commerce of Medicines & Health Products Importers & Exporters (CCCMHPIE) says in a report that local companies are losing market share rapidly due to lagging technology, unfair domestic pricing policies, distribution and other problems. Industry players call for the establishment of a cooperation platform for relevant business communities to prevent the further erosion of the local market. (Click here for more)